Biomira to Present at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference
08 Maio 2007 - 10:00AM
PR Newswire (US)
EDMONTON, May 8 /PRNewswire-FirstCall/ -- Biomira Inc.
(NASDAQ:BIOM) (TSX: BRA) today announced that Robert Kirkman, M.D.,
President and Chief Executive Officer, is scheduled to present at
the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare
Conference at 3:35pm CEST/9:35am EDT/6:35am PDT on Monday, May 14th
in Monte Carlo, Monaco. The presentation is planned for a live
webcast and can be accessed at:
http://www.wsw.com/webcast/rrshq11/biom and at the Biomira website
(http://www.biomira.com/). Biomira intends to make a recording of
the webcast available on the Biomira website approximately one hour
after completion of the presentation. The presentation will be
archived for 90 days. About Biomira Biomira is a biotechnology
company specializing in the development of innovative therapeutic
products for the treatment of cancer. Biomira's goal is to develop
and commercialize novel synthetic vaccines and targeted small
molecules that have the potential to improve the lives and outcomes
of cancer patients. DATASOURCE: Biomira Inc. CONTACT: Investor and
Media Relations Contact: Stephanie H. Seiler, Ph.D., Gemini
BioProjects LLC, (206) 713-0124,
Copyright
Biomira Inc. - Common Shares (MM) (NASDAQ:BIOM)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Biomira Inc. - Common Shares (MM) (NASDAQ:BIOM)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
Notícias em tempo-real sobre Biomira Inc. - Common Shares (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Biomira Inc. - Common Shares (MM)